Search
for
Sort by
Research 91–120 of 251
- Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
- Post COVID Alopecia in the Indian Subcontinent - A Harbinger of Disease Severity
- Long COVID in vaccinated women with Polycystic Ovary Syndrome: A retrospective cohort pilot study
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Dermatological Manifestations of COVID-19: A Brief Review
- The role of hair follicles and Edar signalling in cutaneous wound healing
- 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double Blind Placebo Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Association of androgenetic alopecia with a more severe form of COVID-19 infection
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
- Male reproductive health after 3 months from SARS-CoV-2 infection: a multicentric study
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies